Title:
【発明の名称】フィブリノーゲン受容体拮抗物質
Document Type and Number:
Japanese Patent JP2000514061
Kind Code:
A
Abstract:
Fibrinogen receptor antagonists having the structure X-Y-Z-A-B and pharmaceutically acceptable salts, wherein X is a 5, 6 or 7 membered aromatic or nonaromatic ring, and Y is a 5 or 6 membered aromatic ring, e.g., formula (I).
Inventors:
Mark Yi, Datsugan
Egbertson, Melitsa S
Hartman, Yogyi Day
Young, Stephen Day
Isle, Nathan Sea
Egbertson, Melitsa S
Hartman, Yogyi Day
Young, Stephen Day
Isle, Nathan Sea
Application Number:
JP50429198A
Publication Date:
October 24, 2000
Filing Date:
June 25, 1997
Export Citation:
Assignee:
Merck End Company, Inc.
International Classes:
C07D295/08; A61K31/40; A61K31/4355; A61K31/437; A61K31/44; A61K31/4409; A61K31/445; A61K31/4545; A61K31/495; A61K31/496; A61K31/519; A61P7/02; C07D207/14; C07D209/08; C07D209/46; C07D211/26; C07D211/34; C07D211/62; C07D213/53; C07D213/55; C07D213/56; C07D213/70; C07D213/73; C07D213/74; C07D213/75; C07D213/82; C07D295/14; C07D295/155; C07D295/20; C07D333/40; C07D333/70; C07D401/04; C07D471/04; C07D487/04; C07D491/04; C07D491/048; (IPC1-7): C07D207/14; A61K31/40; A61K31/4355; A61K31/437; A61K31/44; A61K31/4409; A61K31/445; A61K31/4545; A61K31/495; A61K31/496; A61K31/519; A61P7/02; C07D209/08; C07D209/46; C07D211/26; C07D211/34; C07D211/62; C07D213/55; C07D213/56; C07D213/73; C07D213/74; C07D213/75; C07D295/08; C07D295/14; C07D295/20; C07D333/40; C07D401/04; C07D471/04; C07D487/04; C07D491/048
Attorney, Agent or Firm:
Yoshio Kawaguchi (2 outside)